Portal Vein Embolization with Ethylene Vinyl Alcohol Copolymer for Contralateral Lobe Hypertrophy before Liver Resection: Safety, Feasibility, and Initial Experience
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Portal Vein Embolization with Ethylene Vinyl Alcohol Copolymer for Contralateral Lobe Hypertrophy before Liver Resection: Safety, Feasibility, and Initial Experience ; volume:04 ; number:03 ; year:2020
Konferenz: PAIRS Annual Meeting; 2020-02-26; Grand Hyatt Hotel, Dubai UAE
The Arab journal of interventional radiology ; 04, Heft 03 (2020)
- Beteiligte Personen und Organisationen
-
Loffroy, Romaric
Mastier, Charles
Falvo, Nicolas
Pilleul, Frank
Facy, Olivier
Midulla, Marco
Chevallier, Olivier
- DOI
-
10.1055/s-0041-1729027
- URN
-
urn:nbn:de:101:1-2021081212362238047127
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Loffroy, Romaric
- Mastier, Charles
- Falvo, Nicolas
- Pilleul, Frank
- Facy, Olivier
- Midulla, Marco
- Chevallier, Olivier
Ähnliche Objekte (12)
Radioembolization versus portal vein embolization for contralateral liver lobe hypertrophy: effect of cirrhosis
Non-target embolic events during prostatic embolization with ethylene vinyl alcohol copolymer (EVOH)
Embolization of Type 2 Endoleaks in the Abdominal Aorta Using Ethylene Vinyl Alcohol Copolymer
Complex Renal Arteriovenous Malformation (AVM) Embolization using Ethylene Vinyl Alcohol (EVOH) Copolymer and a Balloon Microcatheter
Phosphine oxide for reducing flammability of ethylene-vinyl-acetate copolymer
Dosimetric parameters predicting contralateral liver hypertrophy after unilobar radioembolization of hepatocellular carcinoma
Percutaneous Management of Postoperative Bile Leaks with an Ethylene Vinyl Alcohol Copolymer (Onyx)
Superiority of Intrasac Ethylene Vinyl Alcohol Copolymer Liquid Embolic (Onyx®) Embolization Compared with Other Embolization Agents and Techniques for the Treatment of Type II Endoleaks Following Endovascular Stent-Graft Treatment of Abdominal Aortic Aneurysms
Hepatic hypertrophy and hemodynamics of portal venous flow after percutaneous transhepatic portal embolization
Prostate Artery Embolization for Complete Urinary Outflow Obstruction Due to Benign Prostatic Hypertrophy
Outcomes of Type II Endoleak Treatment using High Volume Ethylene Vinyl Alcohol Copolymer (ONYX®)
Influence of cholestasis on portal vein embolization-induced hypertrophy of the future liver remnant
Radioembolization versus portal vein embolization for contralateral liver lobe hypertrophy: effect of cirrhosis
Non-target embolic events during prostatic embolization with ethylene vinyl alcohol copolymer (EVOH)
Embolization of Type 2 Endoleaks in the Abdominal Aorta Using Ethylene Vinyl Alcohol Copolymer
Complex Renal Arteriovenous Malformation (AVM) Embolization using Ethylene Vinyl Alcohol (EVOH) Copolymer and a Balloon Microcatheter
Phosphine oxide for reducing flammability of ethylene-vinyl-acetate copolymer
Dosimetric parameters predicting contralateral liver hypertrophy after unilobar radioembolization of hepatocellular carcinoma
Percutaneous Management of Postoperative Bile Leaks with an Ethylene Vinyl Alcohol Copolymer (Onyx)
Superiority of Intrasac Ethylene Vinyl Alcohol Copolymer Liquid Embolic (Onyx®) Embolization Compared with Other Embolization Agents and Techniques for the Treatment of Type II Endoleaks Following Endovascular Stent-Graft Treatment of Abdominal Aortic Aneurysms
Hepatic hypertrophy and hemodynamics of portal venous flow after percutaneous transhepatic portal embolization
Prostate Artery Embolization for Complete Urinary Outflow Obstruction Due to Benign Prostatic Hypertrophy
Outcomes of Type II Endoleak Treatment using High Volume Ethylene Vinyl Alcohol Copolymer (ONYX®)
Influence of cholestasis on portal vein embolization-induced hypertrophy of the future liver remnant
Radioembolization versus portal vein embolization for contralateral liver lobe hypertrophy: effect of cirrhosis
Non-target embolic events during prostatic embolization with ethylene vinyl alcohol copolymer (EVOH)
Embolization of Type 2 Endoleaks in the Abdominal Aorta Using Ethylene Vinyl Alcohol Copolymer
Complex Renal Arteriovenous Malformation (AVM) Embolization using Ethylene Vinyl Alcohol (EVOH) Copolymer and a Balloon Microcatheter
Phosphine oxide for reducing flammability of ethylene-vinyl-acetate copolymer
Dosimetric parameters predicting contralateral liver hypertrophy after unilobar radioembolization of hepatocellular carcinoma
Percutaneous Management of Postoperative Bile Leaks with an Ethylene Vinyl Alcohol Copolymer (Onyx)
Superiority of Intrasac Ethylene Vinyl Alcohol Copolymer Liquid Embolic (Onyx®) Embolization Compared with Other Embolization Agents and Techniques for the Treatment of Type II Endoleaks Following Endovascular Stent-Graft Treatment of Abdominal Aortic Aneurysms
Hepatic hypertrophy and hemodynamics of portal venous flow after percutaneous transhepatic portal embolization
Prostate Artery Embolization for Complete Urinary Outflow Obstruction Due to Benign Prostatic Hypertrophy
Outcomes of Type II Endoleak Treatment using High Volume Ethylene Vinyl Alcohol Copolymer (ONYX®)